Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03479957
Other study ID # RemoteCR SWE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 3, 2019
Est. completion date February 28, 2024

Study information

Verified date May 2023
Source Umeå University
Contact Camilla Sandberg, PhD
Phone +46907858441
Email camilla.sandberg@umu.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Supervised exercise is an essential component of contemporary center-based cardiac rehabilitation (CR) programs. Despite the proven effectiveness, uptake and adherence to supervised exercise-based CR (exCR) remains suboptimal (approximately 50%), especially in rural and remote areas of Sweden. The main reasons for low participation rate in centre-based exCR are different accessibility barriers i.e. long distances, transportation problems or employment commitments. In this randomised clinical trial, the overall aim is to evaluate the effectiveness of, home-based, remotely monitored and coached exCR using the REMOTE-CR system compared to home-based exCR based on individualized information regarding current exercise recommendations but without monitoring and coaching (usual care) to improve exercise capacity. Our hypothesis is that remotely monitored and coached exCR will improve exercise capacity to a greater extent than home-based exCR without monitoring and coaching (usual care).


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date February 28, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Scheduled appointment with physiotherapist for follow-up after cardiac event: ----Myocardial Infarction (MI) - Per cutaneous coronary intervention (PCI) due to MI or angina pectoris - Open heart surgery due to coronary artery disease or valvar disease - Living in the catchment area of Heart centre, University Hospital of Umeå. Exclusion Criteria: - Clinically unstable - Postoperative infection - Comorbidity affecting ability to participate in exCR

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
REMOTE-CR
The patients randomized to remotely monitored exercise can either work out with self-selected activities e.g. Nordic-walking, cycling, skiing or participate in supervised exercise session via video link. Remotely monitored exercise training sessions will be offered monday-friday 13.00-16.00.
Other:
Control
The patients randomized to be controls will receive individualized information and instructions regarding current exercise recommendations but will not be monitored or coached during their exercise sessions (usual care)

Locations

Country Name City State
Sweden Umeå University Hospital Umeå

Sponsors (1)

Lead Sponsor Collaborator
Umeå University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Evaluation of change the participation rate in supervised cardiac rehabilitation Evaluation of change the participation rate can be enhanced using the REMOTE -CR system 12 weeks
Other Patients experiences of REMOTE-CR and and exercise led via video link The study participants experience of the REMOTE-CR system and exercise sessions via video link will be evaluated using a questionnaire 12 weeks
Primary Change in submaximal aerobic exercise capacity The aerobic exercise capacity (W) will be evaluated using a standardised submaximal exercise test on cycle ergometer Baseline and 12 weeks
Secondary Muscle endurance capacity Number of repetitions achieved during test of Unilateral isotonic shoulder flexion and Unilateral isotonic heel-lift Baseline and 12 weeks
Secondary Isometric grip strength Isometric grip strength will be evaluated using a hydraulic hand dynamometer Baseline and 12 weeks
Secondary Self-reported physical activity using theInternational Physical Activity Questionnaire International Physical Activity Questionnaire: Results will be presented as a continuous variable, total metabolic equivalent (MET) minutes per week, where a higher score indicates a higher physical activity level. Result will also be presented as a categorical variable:
High Physical activity level: achieving a total physical activity of at least 3000 MET-minutes/week.
Moderate physical activity: achieving a minimum of at least 600 MET-minutes per week.
Low physical activity level: not achieving the minimum of 600 MET minutes per week
Baseline and 12 weeks
Secondary Self-reported physical activity using the physical activity scale br Frändin and Grimby The Activity scale by Frändin and Grimby describes 6 levels of physical activity. The scale includes 6 items that ranges from 1 indicating mostly physically inactive to 6 indicating a very high physical activity level. Baseline and 12 weeks
Secondary Kinesiophobia (fear of movement) The Swedish version of the Tampa scale for Kinesiophobia Heart (TSK-SV Heart) The scale comprises 17 items assessing subjective rating of kinesiophobia. The total score varies between 17-68 and a score >37 defines a high level of kinesofobia. Baseline and 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05330338 - Genetics of Ventriculo-arterial Discordance N/A
Withdrawn NCT03405636 - Xeltis Pulmonary Valved Conduit Safety and Performance Study N/A
Completed NCT02443662 - Colloid Osmotic Pressure in Patients With Fontan Circulation
Terminated NCT02519335 - Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation Phase 1
Completed NCT01835392 - Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery N/A
Completed NCT00371891 - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) Phase 4
Completed NCT03035552 - CTICU Pacifier Activated Music Player and Mother's Voice N/A
Recruiting NCT04581668 - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease N/A
Enrolling by invitation NCT04866537 - Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
Completed NCT03049540 - Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function Phase 3
Completed NCT02377674 - Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection N/A
Completed NCT01679275 - Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
Terminated NCT00543309 - Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery Phase 2
Completed NCT03957512 - Livet Skal Leves (A Life to Live)
Recruiting NCT06005428 - Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Phase 2
Recruiting NCT02691689 - Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions N/A
Completed NCT02306057 - Fluid Balance in Children Undergoing Fontan Surgery N/A
Recruiting NCT02157597 - NIRS Guidance Trail in Children's Heart Surgery N/A
Completed NCT01570933 - Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants. Phase 4
Completed NCT00443599 - SPECS: Safe Pediatric Euglycemia in Cardiac Surgery N/A